The VEGF Inhibitor Axitinib Has Limited Effectiveness as a Therapy for Adrenocortical Cancer

CONTEXT: Adrenocortical carcinoma (ACC) is a rare malignancy with a poor prognosis in need of more effective treatment options. Published evidence indicates many ACCs express the vascular endothelial growth factor receptor (VEGFR), suggesting inhibiting vascular endothelial growth factor signaling c...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: O'Sullivan, Ciara, Edgerly, Maureen, Velarde, Margarita, Wilkerson, Julia, Venkatesan, Aradhana M., Pittaluga, Stefania, Yang, Sherry X., Nguyen, Dat, Balasubramaniam, Sanjeeve, Fojo, Tito
Formato: Artigo
Idioma:Inglês
Publicado: Endocrine Society 2014
Assuntos:
Endocrine Care
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3973787/
https://ncbi.nlm.nih.gov/pubmed/24423320
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2013-2298
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares